| Intrathecal Triamcinolone for Intractable Postherpetic Neuralgia. |
|
Kyung Im Lim, Kye Hyun Kim, Choong Yun Lee |
1Department of Anesthesiology and Pain Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. kyungim.lim@samsung.com
2Department of Obstetric & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. |
|
|
|
|
|
| Abstract |
BACKGROUND
There is no effective treatment for intractable postherpetic neuralgia. Some reports noticed effectiveness of intrathecal steroid administration which was injected at L2/3, L3/4 interspace. We tried the same procedure but injection site was differed to reduce the steroid dose. And then we evaluated the effectiveness and neurologic complications.
METHODS
We studied 9 patients with postherpetic neuralgia.
The patients received intrathecal triamcinolone and mepivacaine (2ml of 0.5% mepivacaine with 15 mg of triamcinolone). Each weekly dose was injected into the lesion site or near the site. Pain was evaluated 1 week, 1 month and then more than 3 months after the treatment.
RESULTS
We found that pain intensity was decreased by 69.7% one week after the treatment, by 70% 3-9 months after the treatment. During the treatment, all patients except two took analgesics but did not at the end of treatment.
CONCLUSIONS
The results of this trial indicated that the intrathecal administration of triamcinolone was effective for postherpetic neuralgia pain management. |
| Key Words:
intrathecal injection; postherpetic neuralgia |
|
PDF Links
Full text via DOI
Download Citation
